Understanding vendor management challenges in Decentralized Clinical Trials (DCT, aka Hybrid and Virtual Trials)

The purported benefits of decentralized clinical trials (DCT) include accelerated enrollment, reduced patient burden and improved retention rates, among other efficiencies. Incorporating virtual elements into the traditional trial model requires a clear vision for the technologies, platforms and other "site-less" elements that support these efforts; however, the potential challenges of managing multiple vendors are often overlooked. This article discusses key considerations for vendor management, auditing and scalability in today's evolving clinical trial landscape.

Copy and paste this URL:

https://biopharma.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/Blog/DCT%20Blog%20post.jpg